Patent ID: 7691853
Filing Date: 2010-04-06
Classification: A61P,C07D

Abstract:
1. A compound of formula IV: or a pharmaceutically acceptable salt thereof, wherein: ring D is a 5-7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl, said heteroaryl or heterocyclyl ring having 1-4 ring heteroatoms selected from nitrogen, oxygen or sulfur, wherein ring D is independently substituted at any substitutable ring carbon by oxo or —R R T is a valence bond or a C R R each R is independently selected form hydrogen or an optionally substituted group selected from C each R each R V is —O—, —S—, —SO—, —SO each R each R wherein said heterocyclyl or heteroaryl ring contains 1-4 heteroatoms selected from N, O, and S; wherein optional substituents on the unsaturated carbon atom of an aryl, heteroaryl, aralkyl, or heteroaralkyl group are selected from a halogen, —R wherein R wherein optional substituents on a saturated carbon of an aliphatic group or of a non-aromatic heterocyclic ring is selected from those listed above for the unsaturated carbon of an aryl or heteroaryl group and the following: ═O, ═S, ═NNHR*, ═NN(R*) wherein optional substituents on the nitrogen of a non-aromatic heterocyclic ring are selected from —R